BIOSIG TECHNOLOGIES INC (BSGM)

Company Profile

BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. The company is headquartered in Westport, Connecticut and currently employs 47 full-time employees. The company went IPO on 2014-09-22. The firm is focused on commercializing an advanced digital signal processing technology platform to deliver insights to the treatment of cardiovascular arrhythmias. Its product PURE EP System is a non-invasive class II device consisting of a combination of hardware and software designed to provide signal clarity and precision for real-time visualization of intracardiac signals, paving the way for personalized patient care. PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated with signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.

Company Info

BIOSIG TECHNOLOGIES INC

55 Greens Farms Road

Westport CONNECTICUT 06880

P: 12034095444

CEO: Kenneth L. Londoner

Employees: 47

Website: https://www.biosig.com/